Monthly archive | PharmaTutor

Read more about New method to kill brain cancer with skin cells

In a first, researchers have developed a method to turn skin cells into cancer-hunting stem cells that can destroy brain tumours known as glioblastoma.

Read more about Speech sounds can help autistic kids develop linguistic skills

Children with autism who often suffer impairments in communication can develop their speech, gestures and a sense of rhythm and melody by listening to various speech sounds, says a study.

26 February 2016

Work as Pharmacist in ECHS at Station HQ Agartala

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

ECHS invites applications to engage following staffs on contractual basis for its Polyclinic Agartala for a one year, renewable for additional period.

Post: Pharmacist

26 February 2016

Working opportunity for Biologics, Formulations at Biocon - experienced candidates only

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Post: BIOLOGICS, FORMULATIONS

26 February 2016

Application are invited for award of Chinese Government Scholarship 2016

Online applications are invited from Indian nationals for the award of Chinese Government Scholarship 2016 under India-China Cultural Exchange Program for the academic year 2016-17 for higher studies/research/specialized training in the following subject fields.

Chinese Language and Literature, Management, Fine Arts (Painting and Sculpture), Agriculture, Sericulture, Biology, Political Science/International relations. Electronics, Electricals, Economics, Computer Science, Physics ,Chemistry, Civil Engineering, Architecture, Pharmacy.

26 February 2016

Job as Associate Scientific Manager-II at Biocon

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Post: Associate Scientific Manager-II

Read more about AMAG Pharmaceuticals announces FDA approval of New Single-Dose, Preservative-Free Makena®

AMAG Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the company’s single-dose, preservative-free formulation of Makena® (hydroxyprogesterone caproate injection). Makena is the only FDA-approved treatment indicated to reduce the risk of preterm birth in women who are pregnant with one baby and who have spontaneously delivered one preterm baby in the past.

Read more about Boston Scientific receives U.S. FDA approval For ACUITY™ X4 Quadripolar Left Ventricular (LV) leads

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the ACUITY™ X4 Quadripolar Left Ventricular (LV) leads. The FDA approval of the quadripolar leads, the wires that connect cardiac resynchronization therapy (CRT) devices to the heart, marks the first time the company will offer a full X4 CRT system – both the device and the leads – to the U.S. market.

Read more about Medtronic receives FDA approval for expanded Indication Trial in Low-Risk Aortic Stenosis Patients

Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication trial for the CoreValve® Evolut® R System, the first and only next-generation recapturable, self-expanding transcatheter aortic valve replacement (TAVR) system commercially available in the United States. Patients with aortic stenosis, who are at a low surgical mortality risk as determined by a heart team, will be enrolled in the trial.

Read more about PTC Receives Refuse to File Letter from FDA for Translarna™ (ataluren)

PTC Therapeutics, Inc. announced that it received yesterday evening a Refuse to File letter from the United States Food and Drug Administration (FDA) regarding PTC's New Drug Application (NDA) for Translarna™ (ataluren), an oral, first-in-class, protein restoration therapy for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).

Search

February 2016

RECOMMENDED POSTS

Subscribe with us

Jobs by Category